Loss of DNA methyltransferase activity in primed human ES cells triggers increased cell-cell variability and transcriptional repression.
Alexander M TsankovMarc H WadsworthVeronika AkopianJocelyn CharltonSamuel J AllonAleksandra ArczewskaBenjamin E MeadRiley S DrakeZachary D SmithTarjei S MikkelsenAlex K ShalekAlexander MeissnerPublished in: Development (Cambridge, England) (2019)
Maintenance of pluripotency and specification towards a new cell fate are both dependent on precise interactions between extrinsic signals and transcriptional and epigenetic regulators. Directed methylation of cytosines by the de novo methyltransferases DNMT3A and DNMT3B plays an important role in facilitating proper differentiation, whereas DNMT1 is essential for maintaining global methylation levels in all cell types. Here, we generated single-cell mRNA expression data from wild-type, DNMT3A, DNMT3A/3B and DNMT1 knockout human embryonic stem cells and observed a widespread increase in cellular and transcriptional variability, even with limited changes in global methylation levels in the de novo knockouts. Furthermore, we found unexpected transcriptional repression upon either loss of the de novo methyltransferase DNMT3A or the double knockout of DNMT3A/3B that is further propagated upon differentiation to mesoderm and ectoderm. Taken together, our single-cell RNA-sequencing data provide a high-resolution view into the consequences of depleting the three catalytically active DNMTs in human pluripotent stem cells.
Keyphrases
- dna methylation
- single cell
- pluripotent stem cells
- gene expression
- genome wide
- rna seq
- endothelial cells
- cell fate
- transcription factor
- wild type
- cell therapy
- high throughput
- high resolution
- induced pluripotent stem cells
- electronic health record
- mass spectrometry
- big data
- oxidative stress
- machine learning
- deep learning
- signaling pathway
- liquid chromatography
- nucleic acid
- heat stress